ARTICLE | Company News
Ipsen, PeptiDream deal
April 15, 2013 7:00 AM UTC
The companies partnered to discover and develop therapeutic peptides to treat indications of interest to Ipsen, including neurology, endocrinology and oncology. The partners will use PeptiDream's Pept...